Clinical updates, including trial initiations, enrollment status and data readouts and publications: 4D, Abivax, Apellis, Biocardia, Menarini, Moleculin, Pfizer, Vaccibody.
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications, including: Algernon, Cytodyn, Fibrogen, Immutep, Montreal Heart Institute, Noxopharm, Revimmune.
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Biocartis, Intact Vascular, Neovasc, Royal Philips.